Lehrstuhl für Geburtshilfe und Frauenheilkunde

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial (2016) Jueckstock J, Rack B, Friedl TWP, Scholz C, Steidl J, Trapp E, Tesch H, et al. Journal article CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients (2016) Rack B, Jueckstock J, Trapp E, Weissenbacher T, Alunni-Fabbroni M, Schramm A, Widschwendter P, et al. Journal article Double-balloon catheter and sequential oral misoprostol versus oral misoprostol alone for induction of labour at term: a retrospective cohort study (2016) Kehl S, Weiss C, Dammer U, Heimrich J, Beckmann M, Faschingbauer F, Suetterlin M Journal article Chylous ascites after lymphadenectomy for gynecological malignancies (2016) Thiel FC, Parvanta P, Hein A, Mehlhorn G, Lux MP, Renner S, Preisner A, et al. Journal article Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial (2016) Hepp P, Andergassen U, Jaezger B, Trapp E, Alunni-Fabbroni M, Friedl TWP, Hecker N, et al. Journal article Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation (2016) Beckmann M, Sell C, Aydogdu M, Brucker SY, Fehm T, Janni W, Kreienberg R, et al. Journal article Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors (2016) Strick R, Strissel P, Baylin SB, Chiappinelli KB Journal article Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016) Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al. Journal article Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial (2016) Kehl S, Schelkle A, Thomas A, Puhl A, Meqdad K, Tuschy B, Berlit S, et al. Journal article